As part of a strategic initiative, Auxilium Pharmaceuticals has concluded its co-promotion partnership with Oscient Pharmaceuticals for Testim 1% testosterone gel and has leased a biologics manufacturing facility for the commercial development of its injectable enzyme product AA4500. Also, to support the growth of Testim, the company initiated an expansion of its sales force. “Because of AA4500’s potential to be the first, non-surgical, biologic treatment option for patients wit...